TY - JOUR T1 - METABOLISM, PHARMACOKINETICS, AND EXCRETION OF THE SUBSTANCE P RECEPTOR ANTAGONIST CP-122,721 IN HUMANS: STRUCTURAL CHARACTERIZATION OF THE NOVEL MAJOR CIRCULATING METABOLITE 5-TRIFLUOROMETHOXY SALICYLIC ACID (TFMSA) BY HPLC/MS/MS AND NMR SPECTROSCOPY JF - Drug Metabolism and Disposition JO - Drug Metab Dispos DO - 10.1124/dmd.106.014266 AU - Kevin A Colizza AU - Mohamed Awad AU - Amin M Kamel Y1 - 2007/03/14 UR - http://dmd.aspetjournals.org/content/early/2007/03/14/dmd.106.014266.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -